» Articles » PMID: 34692738

Feasibility of Droplet Digital PCR Analysis of Plasma Cell-Free DNA From Kidney Transplant Patients

Overview
Specialty General Medicine
Date 2021 Oct 25
PMID 34692738
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Increasing research demonstrates the potential of donor-derived cell-free DNA (dd-cfDNA) as a biomarker for monitoring the health of various solid organ transplants. Several methods have been proposed for cfDNA analysis, including real-time PCR, digital PCR, and next generation sequencing-based approaches. We sought to revise the droplet digital PCR (ddPCR)-based approach to quantify relative dd-cfDNA in plasma from kidney transplant (KTx) patients using a novel pilot set of assays targeting single nucleotide polymorphisms that have a very high potential to distinguish cfDNA from two individuals. The assays are capable of accurate quantification of down to 0.1% minor allele content when analyzing 165 ng of human DNA. We found no significant differences in the yield of extracted cfDNA using the three different commercial kits tested. More cfDNA was extracted from the plasma of KTx patients than from healthy volunteers, especially early after transplantation. The median level of donor-derived minor alleles in KTx samples was 0.35%. We found that ddPCR using the evaluated assays within specific range is suitable for analysis of KTx patients' plasma but recommend prior genotyping of donor DNA and performing reliable preamplification of cfDNA.

Citing Articles

Droplet digital PCR-based testing for donor-derived cell-free DNA in transplanted patients as noninvasive marker of allograft health: Methodological aspects.

Clausen F, Jorgensen K, Wardil L, Nielsen L, Krog G PLoS One. 2023; 18(2):e0282332.

PMID: 36827438 PMC: 9955980. DOI: 10.1371/journal.pone.0282332.


White blood cell count affects fetal fraction and test failure rates in noninvasive prenatal screening.

Qiao L, Cao X, Tang H, Yu Z, Shi J, Xue Y Front Med (Lausanne). 2023; 10:1088745.

PMID: 36817785 PMC: 9932807. DOI: 10.3389/fmed.2023.1088745.


Extracellular vesicle-bound DNA in urine is indicative of kidney allograft injury.

Sedej I, Stalekar M, Znidaric M, Goricar K, Kojc N, Kogovsek P J Extracell Vesicles. 2022; 11(9):e12268.

PMID: 36149031 PMC: 9503341. DOI: 10.1002/jev2.12268.


Digital Droplet PCR in Hematologic Malignancies: A New Useful Molecular Tool.

Galimberti S, Balducci S, Guerrini F, Del Re M, Cacciola R Diagnostics (Basel). 2022; 12(6).

PMID: 35741115 PMC: 9221914. DOI: 10.3390/diagnostics12061305.

References
1.
Dauber E, Kollmann D, Kozakowski N, Rasoul-Rockenschaub S, Soliman T, Berlakovich G . Quantitative PCR of INDELs to measure donor-derived cell-free DNA-a potential method to detect acute rejection in kidney transplantation: a pilot study. Transpl Int. 2019; 33(3):298-309. PMC: 7065216. DOI: 10.1111/tri.13554. View

2.
Bruno D, Ganesamoorthy D, Thorne N, Ling L, Bahlo M, Forrest S . Use of copy number deletion polymorphisms to assess DNA chimerism. Clin Chem. 2014; 60(8):1105-14. DOI: 10.1373/clinchem.2013.216077. View

3.
Kataria A, Kumar D, Gupta G . Donor-derived Cell-free DNA in Solid-organ Transplant Diagnostics: Indications, Limitations, and Future Directions. Transplantation. 2021; 105(6):1203-1211. DOI: 10.1097/TP.0000000000003651. View

4.
Zou J, Duffy B, Slade M, Young A, Steward N, Hachem R . Rapid detection of donor cell free DNA in lung transplant recipients with rejections using donor-recipient HLA mismatch. Hum Immunol. 2017; 78(4):342-349. PMC: 5595356. DOI: 10.1016/j.humimm.2017.03.002. View

5.
Deprez L, Corbisier P, Kortekaas A, Mazoua S, Beaz Hidalgo R, Trapmann S . Validation of a digital PCR method for quantification of DNA copy number concentrations by using a certified reference material. Biomol Detect Quantif. 2016; 9:29-39. PMC: 5007884. DOI: 10.1016/j.bdq.2016.08.002. View